Rajendra Pangeni

About Rajendra Pangeni

Rajendra Pangeni, With an exceptional h-index of 12 and a recent h-index of 12 (since 2020), a distinguished researcher at North Western University, specializes in the field of Genomics, Cancer Genetics/Epigenetics, Biomarkers, Therapeutics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders

COVID-19 and Long COVID: Disruption of the Neurovascular Unit, Blood-Brain Barrier, and Tight Junctions

Transcriptional control of the cancer-promoting enzyme USP22 in lung cancer cells

MSI2 regulates DNA damage response signaling and tumor progression in murine NSCLC

Musashi-2 (MSI2) regulation of DNA damage response in lung cancer

Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression

NSD histone methyltransferases drive cell proliferation in HPV-negative head and neck squamous cell carcinoma (HNSCC)

The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors

Rajendra Pangeni Information

University

Position

Research Fellow

Citations(all)

668

Citations(since 2020)

602

Cited By

318

hIndex(all)

12

hIndex(since 2020)

12

i10Index(all)

12

i10Index(since 2020)

12

Email

University Profile Page

Google Scholar

Rajendra Pangeni Skills & Research Interests

Genomics

Cancer Genetics/Epigenetics

Biomarkers

Therapeutics

Top articles of Rajendra Pangeni

Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders

2024/3/14

COVID-19 and Long COVID: Disruption of the Neurovascular Unit, Blood-Brain Barrier, and Tight Junctions

2023/9/11

Transcriptional control of the cancer-promoting enzyme USP22 in lung cancer cells

2023/4/14

MSI2 regulates DNA damage response signaling and tumor progression in murine NSCLC

Cancer Research

2023/4/4

Musashi-2 (MSI2) regulation of DNA damage response in lung cancer

bioRxiv

2023

Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression

Cell Communication and Signaling

2022/9/19

NSD histone methyltransferases drive cell proliferation in HPV-negative head and neck squamous cell carcinoma (HNSCC)

Cancer Research

2022/6/15

The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors

2022/6

Genome-wide methylation analyses identifies non-coding RNA genes dysregulated in breast tumours that metastasise to the brain

Scientific Reports

2022/1/20

G9a promotes invasion and metastasis of non–small cell lung cancer through enhancing focal adhesion kinase activation via NF-κB signaling pathway

Molecular Cancer Research

2021/3/1

G9a regulates tumorigenicity and stemness through genome-wide DNA methylation reprogramming in non-small cell lung cancer

Clinical epigenetics

2020/12

Cetuximab-triptolide conjugate suppresses the growth of EGFR-overexpressing lung cancers through targeting RNA polymerase II

Molecular Therapy-Oncolytics

2020/9/25

LY6K promotes glioblastoma tumorigenicity via CAV-1–mediated ERK1/2 signaling enhancement

Neuro-oncology

2020/9

Histone methyltransferase G9a promotes migration, invasion of non-small cell lung cancer through enhancing FAK and NF-kB signal pathways

Cancer Research

2020/8/15

Carfilzomib: A potential drug against cisplatin-resistant lung adenocarcinoma

Cancer Research

2020/8/15

Saumya Srivastava
Saumya Srivastava

H-Index: 2

Rajendra Pangeni
Rajendra Pangeni

H-Index: 7

Histone Methyltransferase G9a Promotes Invasion of Non-small Cell Lung Cancer Through Enhancing Focaladhesionkinase Activationvia NF-KB Signaling Pathway

2020/6/17

See List of Professors in Rajendra Pangeni University(North Western University)

Co-Authors

academic-engine